Optik Nörit
Özet
Optik nörit, çocukluk çağında vasküler, enfeksiyöz, neoplastik veya demiyelinizan süreçler gibi çeşitli etiyolojilerle ortaya çıkan akut veya subakut bir görme bozukluğudur. Klinik tablo genellikle görme keskinliğinde azalma, kontrast hassasiyeti kaybı ve afferent pupiller refleks defekti ile seyretmekte olup, tanıda detaylı nörooftalmolojik değerlendirme ve etiyolojik araştırmalar kritik rol oynar. Tedavi stratejileri altta yatan nedene göre şekillenmekte; erken tanı ve uygun immünsupresif yaklaşımlar hastanın görme prognozunu doğrudan belirlemektedir.
Optic neuritis is characterized by acute or subacute visual impairment in children, arising from diverse etiologies such as vascular, infectious, neoplastic, or demyelinating processes. The clinical presentation frequently involves reduced visual acuity, loss of contrast sensitivity, and afferent pupillary reflex defects, necessitating comprehensive neuro-ophthalmological evaluation and targeted etiological diagnostics. Management is heavily dependent on the underlying cause, where timely intervention and appropriate immunosuppressive therapies are critical for optimizing long-term visual outcomes.
Referanslar
Collinge JE, Sprunger DT. Update in pediatric optic neuritis. Curr Opin Ophthalmol. 2013;24(5):448-452.
Gise RA, Heidary G. Update on pediatric optic neuritis. Curr Neurol Neurosci Rep. 2020 Mar 3;20(3):4 doi: 10.1007/s11910-020-1024-x.
El-Dairi MA, Ghasia F, Bhatti MT. Pediatric optic neuritis. Int Ophthalmol Clin. 2012;52(3):29-49.
Banwell B, Kennedy J, Sadovnick D, Arnold DL, Magalhaes S, Wambera K, et al. Incidence of acquired demyelination of CNS in canadian children. Neurology. 2009;72(3):232-239.
Gottlieb-Smith R, Waldman AT. First presentation of an acquired demyelinating syndrome. J Pediatr Neurol 2018;16:164-170.
Lehman SS, Lavrich JB. Pediatric optic neuritis. Curr Opin Ophthalmol. 2018;29(5):419-422.
Waldman AT, Stull LB, Galetta SL, Balcer LJ, Liu GT. Pediatric optic neuritis and risk of multiple sclerosis: meta-analysis of abservationaş studies. AAPOS. 2011;15(5):441-446.
Yeh EA, Graves JS, Benson LA, Wassmer E, Waldman A. Pediatric optic neuritis. Neurology 2016;87(9 Suppl 2):S53-58.
Wilejto M, Shroff M, Buncic JR, Kennedy J, Goia C. The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology. 2006;67(2):258-262.
Pérez-Cambrodí RJ, Cubillana AGH, Merino-Suárez ML, Piñero-Llorens DP, Laria-Ochaita C. Optic neuritis in pediatric population: a review in current tendencies of diagnosis and management. J Optom 2014;7(3):125-130.
Chang MY, Pineles SL. Pediatric optic neuritis. Semin Pediatr Neurol. 2017;24(2):122-128.
Borchert M, Liu GT, Pineles S, Waldman AT. Pediatric Optic Neuritis: What Is New. J Neuroophthalmol. 2017;37 (Suppl 1):S14-S22.
Yilmaz Ü, Gücüyener K, Erin DM, Yazar Z, Gürkaş E, Serdaroğlu A, et al. Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis. Child Neurol. 2012;27(12):1517-1523
Ramdas S, Morrison D, Absoud M, Lim M. Acute onset blindness: a case of optic neuritis and review of childhood optic neuritis. BMJ Case Report. 2016:bcr2016214929.
Ramanathan S, Dale RC, Brilot F. Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmun Rev. 2016;15(4):307-324.
Gunbey C, Konuskan B. Optic neuropathies in childhood: a review of etiology and treatment. Turk J Pediatr.2019;61(4):471-476.
Dale RC, Brilot F, Banwell B. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol. 2009;22(3):233-240
Heussinger N, Kontopantelis E, Gburek-Augustat J, Jenke A, Vollrath G, Korinthenberg R, et al. Oligoclonal bands predict multiple sclerosis in children with optic neuritis. Ann Neurol 2015;77(6):1076-1082.
Bonhomme GR, Waldman AT, Balcer LC, Daniels AB, Tennekoon GI, Forman S, et al. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis. Neurology. 2009;72(10):881-885
Hacohen Y, Absoud M, Deiva K, Hemingway C, Nytrova P, Woodhall M, et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm. 2015;2(2):e81.
Baumann M, Sahin K, Lechner C, Hennes EM, Schanda K, Mader S, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry. 2015;86(3):265-272.
Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015 Jul 14;85(2):177-189.
Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015;84(11):1165-1173.
Mateo J, Esteban O, Martínez M, Grzybowski A, Ascaso FJ. The Contribution of Optical Coherence Tomography in Neuromyelitis Optica Spectrum Disorders. Front Neurol. 2017;8:493. doi: 10.3389/fneur.2017.00493.
Hacohen Y, Banwell B. Treatment approaches for MOG-Ab-Associated demyelination in children. Curr Treat Options Neurol. 2019;21(1):2
Song H, Zhou H, Yang M, Xu Q, Sun M, Wei S.Clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis in varying age groups: A cohort study in China.Clinical J Neurol Sci. 2019;400:83-89.
Chen Q, Zhao G, Huang Y, Li Z, Sun X, Lu P, et al. Clinical characteristics of pediatric optic neuritis with myelin oligodendrocyte glycoprotein seropositive: a cohort study. Pediatr Neurol. 2018;83:42-49.
Narayan RN, McCreary M, Conger D, Wang C, Greenberg BM. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients. Mult Scler Relat Disord. 2019;28:86-90. doi: 10.1016/j.msard.2018.11.026.
Kidd D, Burton B, Plant GT, Graham EM. Chronic relapsing inflammatory optic neuropathy (CRION).Brain. 2003;126(Pt 2):276-284.
Pineles SL, Liu GT, Waldman AT, Lazar E, Kupersmith MJ, Repka MX; Pediatric Eye Disease Investigator Group and the Neuro-Ophthalmology Research Disease Investigator Consortium. Pediatric Optic Neuritis Prospective Outcomes Study. J Neuroophthalmol. 2016;36(2):115-117.
Pula JH, Macdonald CJ. Current options for the treatment of optic neuritis. Clin Ophthalmol. 2012;6:1211-1223.
Jayakody H, Bonthius DJ, Longmuir R, Joshi C. Pediatric optic neuritis: does a prolonged course of steroids reduce relapses? A preliminary study. Pediatr Neurol. 2014;51(5):721-725.
Gal RL, Vedula SS, Beck R. Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev. 2015;2015(8):CD001430
Hacohen Y, Wong YY, Lechner C, Jurynczyk M, Wright S, Konuskan B, et al. Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurol. 2018;75(4):478-487.
Gmuca S, Xiao R, Weiss PF, Waldman AT, Gerber JS. Use of Rituximab and Risk of Re-hospitalization for Children with Neuromyelitis Optica Spectrum Disorder. Mult Scler Demyelinating Disord. 2018 Apr;3:3. doi: 10.1186/s40893-018-0035-9.
